A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Mivacurium | Mivacurium. Uses: For analytical and research use. Group: Impurity standards. CAS No. 133814-19-4. Molecular Formula: C58H80N2O142+. Mole Weight: 1029.28. Catalog: APB133814194. |  |
| Mivacurium | Mivacurium is a bisbenzylisoquinolinium based and a short-duration non-depolarizing neuromuscular-blocking drug or skeletal muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, which results in a block of neuromuscular transmission. It is used in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during mechanical ventilation or surgery. Uses: Mivacurium is a short-duration non-depolarizing neuromuscular-blocking drug or skeletal muscle relaxant. Synonyms: 2, 2'-[ (1, 8-Dioxo-4-octene-1, 8-diyl) bis (oxy-3, 1-propanediyl) ]bis[1, 2, 3, 4-tetrahydro-6, 7-dimethoxy-2-methyl-1-[ (3, 4, 5-trimethoxyphenyl) methyl]isoquinolinium; Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-;Bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate;BW-B-1090U;Mivacron;(1R,1'R)-2,2'-((((E)-oct-4-enedioyl)bis(oxy))bis(propane-3,1-diyl))bis(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-ium). Grades: 95%. CAS No. 106791-40-6. Molecular formula: C58H80N2O14. Mole weight: 1029.28. |  |
| Mivacurium chloride | Mivacurium is a nicotinic acetylcholine receptors (nAChRs) antagonist and a non-depolarizing neuromuscular-blocking drug metabolized by plasma cholinesterase. Grades: ≥95%. CAS No. 106861-44-3. Molecular formula: C58H80Cl2N2O14. Mole weight: 1100.2. | |
| Mivacurium Chloride | Mivacurium Chloride. Uses: For analytical and research use. Group: Impurity standards. CAS No. 106861-44-3. Molecular Formula: C58H80Cl2N2O14. Mole Weight: 1100.18. Catalog: APB106861443. | |
| Mivacurium Chloride Impurity 1 | Mivacurium Chloride Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 733704-04-6. Molecular Formula: C25H36NO6+. Mole Weight: 446.56. Catalog: APB733704046. | |
| Mivacurium Chloride Impurity 11 | Mivacurium Chloride Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 104758-51-2. Molecular Formula: C58H80Cl2N2O14. Mole Weight: 1100.18. Catalog: APB104758512. | |
| Mivacurium Chloride Impurity 12 | Mivacurium Chloride Impurity 12. Uses: For analytical and research use. Group: Impurity standards. CAS No. 107740-63-6. Molecular Formula: C58H80Cl2N2O14. Mole Weight: 1100.18. Catalog: APB107740636. | |
| Mivacurium Chloride Impurity 13 | Mivacurium Chloride Impurity 13. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (1R,1'R,2R,2'R)-2,2'-((((E)-oct-4-enedioyl)bis(oxy))bis(propane-3,1-diyl))bis(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-ium) chloride. CAS No. 107740-65-8. Molecular Formula: C58H80N2O14·2Cl. Mole Weight: 1098.5. Catalog: APB107740658. | |
| Mivacurium Chloride Impurity 14 | Mivacurium Chloride Impurity 14. Uses: For analytical and research use. Group: Impurity standards. CAS No. 61349-11-9. Molecular Formula: C21H25NO5. Mole Weight: 371.43. Catalog: APB61349119. | |
| Mivacurium Chloride Impurity 15 | Mivacurium Chloride Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)(3,4,5-trimethoxyphenyl)methanone. CAS No. 1445585-61-4. Molecular Formula: C21H23NO6. Mole Weight: 385.15. Catalog: APB1445585614. | |
| Mivacurium Chloride Impurity 15 | Mivacurium Chloride Impurity 15. Uses: For analytical and research use. Group: Impurity standards. CAS No. 7668-86-2. Molecular Formula: C22H27NO5. Mole Weight: 385.46. Catalog: APB7668862. | |
| Mivacurium Chloride Impurity 2 | Mivacurium Chloride Impurity 2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 791546-70-8. Molecular Formula: C25H36NO6+. Mole Weight: 446.56. Catalog: APB791546708. | |
| Mivacurium Chloride Impurity 20 | Mivacurium Chloride Impurity 20. Uses: For analytical and research use. Group: Impurity standards. CAS No. 38561-68-1. Molecular Formula: C8H12O4. Mole Weight: 172.18. Catalog: APB38561681. | |
| Mivacurium Chloride Impurity 21 | Mivacurium Chloride Impurity 21. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1026602-92-5. Molecular Formula: C6H13ClO2. Mole Weight: 152.62. Catalog: APB1026602925. | |
| Mivacurium Chloride Impurity 22 | Mivacurium Chloride Impurity 22. Uses: For analytical and research use. Group: Impurity standards. CAS No. 7668-87-3. Molecular Formula: C21H27NO6. Mole Weight: 389.45. Catalog: APB7668873. | |
| Mivacurium Chloride Impurity 23 | Mivacurium Chloride Impurity 23. Uses: For analytical and research use. Group: Impurity standards. CAS No. 104758-47-6. Molecular Formula: C22H29NO5. Mole Weight: 387.48. Catalog: APB104758476. | |
| Mivacurium Chloride Impurity 29 | Mivacurium Chloride Impurity 29. Uses: For analytical and research use. Group: Impurity standards. CAS No. 161816-38-2. Molecular Formula: C33H46ClNO9. Mole Weight: 636.18. Catalog: APB161816382. | |
| Mivacurium Chloride Impurity 3 | Mivacurium Chloride Impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 740777-60-0. Molecular Formula: C33H46NO9+. Mole Weight: 600.73. Catalog: APB740777600. | |
| Mivacurium Chloride Impurity 30 | Mivacurium Chloride Impurity 30. Uses: For analytical and research use. Group: Impurity standards. CAS No. 161816-39-3. Molecular Formula: C33H46ClNO9. Mole Weight: 636.18. Catalog: APB161816393. | |
| Mivacurium Chloride Impurity 4 | Mivacurium Chloride Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 714192-43-5. Molecular Formula: C33H46NO9+. Mole Weight: 600.73. Catalog: APB714192435. | |
| Mivacurium Chloride Impurity 5 | Mivacurium Chloride Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 7668-85-1. Molecular Formula: C25H36NO6+. Mole Weight: 446.56. Catalog: APB7668851. | |
| Mivacurium Chloride Impurity A | Mivacurium Chloride Impurity A. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (1R,2S)-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-ium chloride. CAS No. 107740-66-9. Molecular Formula: C25H36NO6·Cl. Mole Weight: 482.01. Catalog: APB107740669. | |
| Mivacurium Chloride Impurity B | Mivacurium Chloride Impurity B. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (1R,2R)-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-ium chloride. CAS No. 107740-64-7. Molecular Formula: C25H36NO6·Cl. Mole Weight: 482.01. Catalog: APB107740647. | |
| Mivacurium Chloride Intermediate | Mivacurium Chloride Intermediate. Uses: For analytical and research use. Group: Impurity standards. CAS No. 48059-97-8. Molecular Formula: C8H12O4. Mole Weight: 172.18. Catalog: APB48059978. | |
| Mivacurium Chloride (mixture of isomers) | Non-depolarizing neuromuscular blocking agent. Muscle relaxant (skeletal). Group: Biochemicals. Alternative Names: (1R, 1'R) -2, 2'-[[ (4E) -1, 8-Dioxo-4-octene-1, 8-diyl]bis (oxy-3, 1-propanediyl) ]bis[1, 2, 3, 4-tetrahydro-6, 7-dimethoxy-2-methyl-1-[ (3, 4, 5-trimethoxyphenyl) methyl]-isoquinolinium Chloride ; Mivacron; BW-B 1090U. Grades: Highly Purified. CAS No. 106861-44-3. Pack Sizes: 2.5mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C??H??Cl?N?O??, Molecular Weight: 1100.17. US Biological Life Sciences. |  Worldwide |
| Mivacurium dichloride | Mivacurium dichloride is a benzylisoquinoline derivative and is a short-acting non-depolarizing neuromuscular blocking agent and skeletal muscle relaxant. Mivacurium dichloride couples with the nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the terminal disc of the muscle cell [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 106861-44-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B1700A. |  |
| Mivebresib | Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a K i of 1.5 nM [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ABBV-075. CAS No. 1445993-26-9. Pack Sizes: 10 mM * 1 mL; 2 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100015. | |
| Mivebresib | Mivebresib is a BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. Mivebresib is also a MYC and the TMPRSS2-ETS fusion proteins inhibitor. Mivebresib can inhibit cell growth in susceptible tumors. Uses: Anti-tumor. Synonyms: ABBV-075; ABBV 075; ABBV075; Mivebresib;N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide. Grades: 98%. CAS No. 1445993-26-9. Molecular formula: C22H19F2N3O4S. Mole weight: 459.47. | |
| Mivobulin | Heterocyclic Organic Compound. Alternative Names: CALCIUM MITIGLINIDE;Mivobulin;Ethyl N-[(9S)-5-amino-9-methyl-8-phenyl-4,7,10-triazabicyclo[4.4.0] deca-1,3,5,7-tetraen-3-yl]carbamate;Mivobulin [inn]. CAS No. 122332-18-7. Molecular formula: C17H19N5O2. Mole weight: 325.37. Density: 1.36. Catalog: ACM122332187. |  |
| Mivobulin isethionate | Mivobulin isethionate is the isethionate salt of mivobulin, a synthetic colchicine analogue with potential antineoplastic activity. Mivobulin isethionate binds to tubulin, thereby inhibiting microtubule polymerization and mitosis. Uses: Antineoplastic agents. Synonyms: CI-980; CI 980; CI980. CAS No. 126268-81-3. Molecular formula: C19H25N5O6S. Mole weight: 451.50. | |
| Mivorilaner | Mivorilaner is an antineoplastic and antiparasitic primarily used in veterinary medicine. Synonyms: Itabh-19-01; LY 3116151; LY3116151; LY-3116151. Grades: >98%. CAS No. 1414642-93-5. Molecular formula: C22H17Cl2F6N3O3S. Mole weight: 588.3. | |
| Mix Coal Tar/Petroleum Extract in Methylene Chloride | Mix Coal Tar/Petroleum Extract in Methylene Chloride. Uses: For analytical and research use. Group: Process materials, geological, cement & soils. Catalog: APS009969. Shipping: Room Temperature. | |
| Mixed amino resin | Mixed amino resin. Group: Polymers. |  |
| Mixed bed resin tmd-8 | Heterocyclic Organic Compound. CAS No. 100915-97-7. Purity: 0.96. Catalog: ACM100915977. | |
| Mixed camphor sulfonic acid | Mixed camphor sulfonic acid. Uses: For analytical and research use. Group: Impurity standards. CAS No. 34850-66-3. Molecular Formula: C10H17NaO4S. Mole Weight: 256.29. Catalog: APB34850663. | |
| Mixed tocopherol microencapsulated powder | Mixed tocopherol microencapsulated powder. Product ID: CDF4-0195. Molecular formula: NA. Category: Antioxidant; nutrient supplements. Product Keywords: Food Ingredients; Nutrients; CDF4-0195; Mixed tocopherol microencapsulated powder; Antioxidant; nutrient supplements. Appearance: light yellow powder. Color: light yellow. Physical State: powder. Applications: Dietary supplements, nutritional supplements, cosmetic raw materials, etc. |  |
| Mixed Tocopherols | Mixed Tocopherols. CAS No: 1406-18-4 |  Sarchem Laboratories New Jersey NJ |
| Mixoxantrone HCI | Mixoxantrone HCI. Group: Biochemicals. Grades: Highly Purified. CAS No. 70476-82-3. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C22H28N4O6HCI. US Biological Life Sciences. | Worldwide |
| Mixture of 1,2,3-Propanetriol 2-(Dihydrogen phosphate) Sodium Salt Hydrate and 1,2,3-Propanetriol 1-(Dihydrogen phosphate) Sodium Salt Hydrate | 1,2,3-Propanetriol 2-(Dihydrogen phosphate) is a serine-threonine phosphatase inhibitor. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1g, 10g. Molecular Formula: C3H7Na2O6P xH2O. US Biological Life Sciences. | Worldwide |
| Mixture of Ezetimibe (3R,4R,3'R)-Isomer and Ezetimibe (3R,4R,3'S)-Isomer | A stereoisomer of Ezetimibe. Ezetimibe inhibits intestinal cholesterol absorption by preventing cholesterol uptake by the Niemann-Pick C1-like 1 (NPC1L9) protein, a cholesterol transporter located in the apical membrane of enterocytes. Synonyms: Mixture of Ezetimibe (3R,4R,3'R)-Isomer and Ezetimibe (3R,4R,3'S)-Isomer. Grades: > 95%. Molecular formula: C24H21F2NO3. Mole weight: 409.44. | |
| Mixture of Ezetimibe (3S,4S,3'S)-Isomer and Ezetimibe (3S,4S,3'R)-Isomer | An impurity of Ezetimibe. Ezetimibe inhibits intestinal cholesterol absorption by preventing cholesterol uptake by the Niemann-Pick C1-like 1 (NPC1L34) protein, a cholesterol transporter located in the apical membrane of enterocytes. Synonyms: Mixture of Ezetimibe (3S,4S,3'S)-Isomer and Ezetimibe (3S,4S,3'R)-Isomer. Grades: > 95%. Molecular formula: C24H21F2NO3. Mole weight: 409.44. | |
| Mixture of (R)-Apomorphine-11-sulfate Potassium Salt-d5 + (R)-Apomorphine-10-sulfate. (d4-Major) (90%) | (R)-Apomorphine-11-sulfate Potassium Salt-d5 is the isotope labelled analog of (R)-Apomorphine-11-sulfate Potassium Salt (A727520); a derivative of (R)-Apomorphine (A727500) which is a dopamine (D1 and D2) receptor agonist, emetic, and antiparkinsonian. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug, 5mg. Molecular Formula: C17H11D5KNO5S. US Biological Life Sciences. | Worldwide |
| Mixture of (Z)-3-chloro-Oxybutynin and (Z)-2-chloro-Oxybutynin | Mixture of (Z)-3-chloro-Oxybutynin and (Z)-2-chloro-Oxybutynin(Oxybutynin HCI Adduct Impurity) is an impurity of oxybutynin, which is an inhibitor of proliferation and supresses gene expression in bladder smooth muscle cells. Synonyms: Oxybutynin HCI Adduct Impurity; (Z)-2-chloro-4-(diethylamino)but-2-en-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate compound with (Z)-3-chloro-4-(diethylamino)but-2-en-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate (1:1). Molecular formula: C44H64Cl2N2O6. Mole weight: 787.89. | |
| Miyakamide A1 | Miyakamide A1 is an antibiotic produced by Aspergillus flavus var. columnaris FKI-0739. It has insecticidal effect. Miyakamide A1 inhibits the growth of Artemia salina at a minimum concentration of 5 μg/mL. Miyakamide A1 has weak antixanthomonas activity. It inhibits P388 cells with an IC50 of 10.5 μg/mL. CAS No. 497252-38-7. Molecular formula: C31H32N4O3. Mole weight: 508.61. | |
| Miyakamide A2 | Miyakamide A2 is an antibiotic produced by Aspergillus flavus var. columnaris FKI-0739. It has insecticidal effect. Miyakamide A2 inhibits the growth of Artemia salina at a minimum concentration of 5 μg/mL. Miyakamide A1 has weak antixanthomonas activity. It inhibits P388 cells with an IC50 of 12.2 μg/mL. CAS No. 497252-39-8. Molecular formula: C31H32N4O3. Mole weight: 508.61. | |
| Miyakamide B1 | Miyakamide B1 is an antibiotic produced by Aspergillus flavus var. columnaris FKI-0739. It has insecticidal effect. Miyakamide B1 inhibits the growth of Artemia salina at a minimum concentration of 20 μg/mL. It inhibits P388 cells with an IC50 of 8.8 μg/mL. CAS No. 497182-82-8. Molecular formula: C31H32N4O4. Mole weight: 524.61. | |
| Miyakamide B2 | Miyakamide B2 is an antibiotic produced by Aspergillus flavus var. columnaris FKI-0739. It has insecticidal effect. Miyakamide B2 inhibits the growth of Artemia salina at a minimum concentration of 20 μg/mL. It inhibits P388 cells with an IC50 of 7.6 μg/mL. CAS No. 497182-83-9. Molecular formula: C31H32N4O4. Mole weight: 524.61. | |
| Mizagliflozin | Mizagliflozin is a sodium-glucose transporter inhibitor. It is expected to improve postprandial hyperglycemia by suppressing glucose absorption from the intestine. It blocks intestinal glucose absorption and reduces GIP secretion in rats and humans, which suggests SGLT1 glucose transport is critical for GIP release. It is used for the treatment of diabetes. Synonyms: DSP-3235, DSP3235; DSP 3235; KGA-3235; KGA 3235; KGA3235; GSK-1614235; GSK 1614235; GSK1614235. Grades: 98%. CAS No. 666843-10-3. Molecular formula: C28H44N4O8. Mole weight: 564.68. | |
| Mizagliflozin | Mizagliflozin (DSP-3235 free base) is a potent, orally active and selective SGLT1 inhibitor, with a K i of 27 nM for human SGLT1. Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic agent that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DSP-3235 free base; KGA-3235 free base; GSK-1614235 free base. CAS No. 666843-10-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-17638. | |
| Mizolastine | Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). Mizolastine effectively inhibits mRNA expression of VEGF165 , VEGF120 , TNF-α and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticarial [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 108612-45-9. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg; 1 g. Product ID: HY-B0164. | |
| Mizolastine | A highly selective histamine H1-receptor antagonist (with no anticholinergic, antiadrenergic, or antiserotonin activity) for use in the treatment of allergic disorders, especially rhinitis and urticaria. Group: Biochemicals. Alternative Names: 2- [ [1- [1- [ (4-Fluorophenyl) methyl] -1H-benzimidazol-2-yl] -4-piperidinyl] methylamino] - 4(1H)-pyrimidinone; MKC 431; Mistamine; Mizollen; SL 850324; Zolistan. Grades: Highly Purified. CAS No. 108612-45-9. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Mizolastine dihydrochloride | The dihydrochloride salt form of Mizolastine which is effective in the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and other allergy symptoms for playing the role as a histamine H1-receptor antagonis. IC50: 47nM. Uses: The dihydrochloride salt form of mizolastine which is effective in the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and other allergy symptoms for playing the role as a histamine h1-receptor antagonis. Synonyms: Mizolastine (dihydrochloride); CS-1998. Grades: 98%. CAS No. 1056596-82-7. Molecular formula: C24H27Cl2FN6O. Mole weight: 505.42. | |
| Mizoribine | Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC 50 of approximately 100 μM for anti-HCV activity. Immunosuppressant [1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC 50 s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively [2]. Uses: Scientific research. Group: Natural products. Alternative Names: NSC 289637; HE 69. CAS No. 50924-49-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-17470. | |
| Mizoribine | Mizoribine. Group: Biochemicals. Alternative Names: 1-(b-D-Ribofuranosyl)-5-hydroxyimidazole-4-carboxamide. Grades: Highly Purified. CAS No. 50924-49-7. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C9H13N3O6. US Biological Life Sciences. | Worldwide |
| Mizoribine | Bredinin is a nucleoside antibiotic produced by Eupenicillum brefeldianum M-2166. It has anti-L-5178Y cell and anti-pox virus activity, not against bacteria and fungi. Uses: Anti-inflammatory agents, non-steroidal. Synonyms: N'-(b-D-Ribofuranosyl)-5-hydroxyimidazole-4-carboxamide; Bredinin; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxy-1H-imidazole-4-carboxamide; 5-Hydroxy-1-beta-D-ribofuranosyl-1H-imidazole-4-carboxamide. Grades: ≥95%. CAS No. 50924-49-7. Molecular formula: C9H13N3O6. Mole weight: 259.22. | |
| Mizoribine 5-monophosphate | Mizoribine 5-monophosphate is a widely utilized pharmaceutical compound within the biomedical sector, aiding in studying diverse autoimmune disorders, such as rheumatoid arthritand lupus nephritis. CAS No. 62025-48-3. Mole weight: 259.22. | |
| MJ 15 | MJ 15 is a CB1 receptor antagonist with IC50 value of 118.9 pM for rat CB1 receptors. It can inhibit food intake and increase body weight in diet-induced obese rats and mice. Synonyms: MJ15; MJ 15; MJ-15; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(3-pyridinylmethyl)-1H-pyrazole-3-carboxamide. Grades: ≥99% by HPLC. CAS No. 944154-76-1. Molecular formula: C23H17Cl3N4O. Mole weight: 471.77. | |
| MJ33 lithium salt | MJ33 is a selective and reversible inhibitor of the acidic, calcium-independent (ai)PLA2 activity of Prdx6. Prdx6 is a bifunctional enzyme with both non-selenium glutathione peroxidase (Gpx) and PLA2 activities. Synonyms: 1-Hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol, Li. Grades: ≥95%. CAS No. 1007476-63-2. Molecular formula: C22H43F3LiO6P. Mole weight: 498.5. | |
| MJ347-81F4-B | MJ347-81F4-B is originally isolated from Amycolatopsis sp. MJ347-81F4. It has good anti-gram-positive bacteria activity, including clinically isolated methicillin-resistant Staphylococcus aureus (MIC 0.05-0.2 μg/mL). Molecular formula: C60H58N14O18S5. Mole weight: 1423.51. | |
| MJN110 | MJN110 is a potent and selective monoacylglycerol lipase (MAGL) inhibitor that modulates the synaptic processes. MJN110 has the potential for the treatment of acute nausea and vomiting as well as anticipatory nausea by elevation of endogenous cannabinoid 2-arachidonoylglycerol (2-AG) levels in the brain. Uses: Antihyperalgesic agent. Synonyms: MJN-110; MJN 110; MJN110;2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate. Grades: 98%. CAS No. 1438416-21-7. Molecular formula: C22H21Cl2N3O4. Mole weight: 462.33. | |
| MJN228 | MJN228 is a lipid-binding protein nucleobindin-1 ( NUCB1 ) inhibitor with an IC 50 of 3.3 μM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 459168-97-9. Pack Sizes: 1 mg. Product ID: HY-118319. | |
| MJN228 | MJN228 is a selective ligand for the lipid-binding protein nucleobindin 1 (NUCB1) that blocks probe binding to NUCB1. It prevents AEA-DA probe labeling of NUCB1 with an IC50 value of 3.3 μM in HEK293T cell lysates. Synonyms: (4-methylpiperazin-1-yl)-(5-nitro-3-phenyl-1H-indol-2-yl)methanone. Grades: ≥98%. CAS No. 459168-97-9. Molecular formula: C20H20N4O3. Mole weight: 364.4. | |
| MK-0249 | This active molecular is a potent histamine H3 inverse antagonist. Current antipsychotic treatments have little impact on the cognitive deficits associated with schizophrenia. MK-0249 might improve cognitive deficits in patients with schizophrenia in due to promote histamine release that may enhance cognition. In Dec 2006, Phase-II clinical trials in Alzheimer's disease in USA was on going. In Dec 2009, adverse events data from a clinical trial in healthy subjects was presented. In Jun 2012, Pharmacodynamics data from a phase I trial in Sleep apnoea syndrome was reported by Merck. Uses: Alzheimer's disease; attention-deficit hyperactivity disorder; obesity; schizophrenia; sleep apnoea syndrome. Synonyms: MK0249; MK 0249; MK-0249; 2-methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one. Grades: 98%. CAS No. 1167574-41-5. Molecular formula: C23H24F3N3O2. Mole weight: 431.45. | |
| MK 0343 | MK 0343. Group: Biochemicals. Grades: Purified. CAS No. 233275-76-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MK 0343 | MK 0343, also known as MRK-409, is a subtype-selective GABAA partial agonist (Ki values are 0.21, 0.22, 0.23 and 0.40 for α3, α1, α5 and α2 respectively). MK-0343 is a non-sedating anxiolytic in preclinical species but causes sedation in humans. Synonyms: 7-cyclobutyl-3-(2,6-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine; MK-0343; MK 0343; MK0343; MRK 409; MRK409; MRK-409. Grades: >98%. CAS No. 233275-76-8. Molecular formula: C19H17F2N7O. Mole weight: 397.38. | |
| MK-0354 | MK-0354 is a partial agonist of Niacin receptor, G-protein coupled receptor 109a. Its EC50 value is 1.65/1.08 μM for hGPR109a/ mGPR109a, which show no activation of GPR109b in the cAMP assay at any concentration up to 100 μM. It demonstrated clear and statistically significant partial agonism in the cAMP assays for both the mouse and human receptors with efficacy approximately 60-70% of that of either nicotinic acid or β-hydroxy butyrate in vitro. It appeared to be somewhat unique among the members of the pyrazole tetrazole series in having reasonable receptor activity. It retained the plasma free fatty acid lowering effects in mice, but did not induce vasodilation at the maximum feasible dose in vivo. It could activate the antilipolytic pathway in adipocytes. It was developed by Arena pharmaceuticals and Merck Serono together. It had been in the two phase of clinical and been used for the treatment of atherosclerosis, but it was terminated in 2006. Uses: Mk-0354 could activate the antilipolytic pathway in adipocytes. had been used for the treatment of atherosclerosis. Synonyms: MK-0354; MK0354; MK 0354; 3-(1H-tetrazol-5-yl)-1, 4, 5, 6-tetrahydrocyclopenta[c]pyrazole;1, 4, 5, 6-Tetrahydro-3-(1H-tetrazol-5-yl)cyclopenta[c]pyrazole. Grades: >98%. CAS No. 851776-28-8. Molecular formula: C7H8N6. Mole weight: 176.18. | |
| MK-0359 | MK-0359 is a selective and potent oral PDE4 inhibitor with in vivoefficacy in animal models of asthma and cognition. Uses: Pde4 inhibitor. Synonyms: MK0359; MK 0359; MK-0359; L454560; L 454560; L-454560; 3-methyl-5-[(E)-1-(4-methylsulfonylphenyl)-2-[3-[6-(2-methylsulfonylpropan-2-yl)quinolin-8-yl]phenyl]ethenyl]-1,2,4-oxadiazole. Grades: ≥98%. CAS No. 346629-30-9. Molecular formula: C31H29N3O5S2. Mole weight: 587.15. | |
| MK-0429 | MK-0429 is a potent alpha(nu)beta(3) integrin inhibitor (or αvβ3 inhibitor), which showed therapeutic effects on bone turnover disease in men with hormone-refractory prostate cancer (HRPC) and bone metastases. Clinical trial results showed that MK-0429 was generally well tolerated, with the most common side-effect being nausea. There was some evidence of an early reduction of bone turnover, indicating a potential for clinical use in the treatment of bone mineral density (MBD) although serum PSA was unexpectedly increased during the study. Synonyms: L-000845704; (S)-3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid; NSC776790; 3-Pyridinepropanoic acid, 6-methoxy-β-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-, (βS)-. Grades: >98%. CAS No. 227963-15-7. Molecular formula: C23H29N5O4. Mole weight: 439.51. | |
| MK 0434 | MK 0434 is a Cholestenone 5-alpha reductase inhibitor originated by Merck & Co and it is associated with a significant reduction in dihydrotestosterone. No development was reported for the treatment of Alopecia, Benign prostatic hyperplasia and Prostate cancer. Uses: Alopecia, benign prostatic hyperplasia and prostate cancer. Synonyms: MK0434; MK-0434; MK 0434; MK-434; MK434; MK 434; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-7-benzoyl-4a,6a-dimethyl-1,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-2H-indeno[5,4-f]quinolin-2-one;(5alpha,17beta)-17-Benzoyl-4-azaandrost-1-en-3-one;17beta-Benzoyl-4-aza-5alpha-androst-1-ene-3-one. Grades: 98%. CAS No. 134067-56-4. Molecular formula: C25H31NO2. Mole weight: 377.53. | |
| MK-0493 | MK-0493 is a novel, potent, and selective agonist of MC4R( melanocortin receptor 4) , which is one of the best-validated genetic targets and considered one of the most promising for the development of antiobesity therapeutics. Uses: Anti-obesity. Synonyms: MK0493; MK 0493; MK-0493; N-((S)-1-(2-(1-((3S,4R)-1-(tert-butyl)-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl)piperidin-4-yl)-5-chlorophenyl)ethyl)acetamide hydrochloride. Grades: ≥98%. CAS No. 455957-71-8. Molecular formula: C30H39Cl2F2N3O2. Mole weight: 582.55. | |
Our database is helping our users find suppliers everyday.
